Allergen manufacturing and quality aspects for allergen immunotherapy in Europe and the United States: An analysis from the EAACI AIT Guidelines Project
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Allergen manufacturing and quality aspects for allergen immunotherapy in Europe and the United States: An analysis from the EAACI AIT Guidelines Project
Authors
Keywords
-
Journal
ALLERGY
Volume 73, Issue 4, Pages 816-826
Publisher
Wiley
Online
2017-11-18
DOI
10.1111/all.13357
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Standardization of allergen products: 3. Validation of candidate European Pharmacopoeia standard methods for quantification of major birch allergen Bet v 1
- (2016) S. Kaul et al. ALLERGY
- Standardization of allergen products: 2. Detailed characterization of GMP-produced recombinant Phl p 5.0109 as European Pharmacopoeia reference standard
- (2016) M. Himly et al. ALLERGY
- Standardization and Regulation of Allergen Products in the European Union
- (2016) Julia Zimmer et al. CURRENT ALLERGY AND ASTHMA REPORTS
- Predominant Api m 10 sensitization as risk factor for treatment failure in honey bee venom immunotherapy
- (2016) Marcel Frick et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- A randomized DBPC trial to determine the optimal effective and safe dose of a SLIT-birch pollen extract for the treatment of allergic rhinitis: results of a phase II study
- (2015) O. Pfaar et al. ALLERGY
- Development and in-house validation of an allergen-specific ELISA for quantification of Bet v 4 in diagnostic and therapeutic birch allergen products
- (2015) Oliver Dehus et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- Control Process for Manufacturing and Standardization of Allergenic Molecules
- (2015) Jerónimo Carnés et al. CURRENT ALLERGY AND ASTHMA REPORTS
- International consensus on allergy immunotherapy
- (2015) Marek Jutel et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- In VitroEvaluation of Allergen Potencies of Commercial House Dust Mite Sublingual Immunotherapy Reagents
- (2015) Kyung Hee Park et al. Allergy Asthma & Immunology Research
- A prospective study comparing the efficacy and safety of two sublingual birch allergen preparations
- (2014) Ludger Klimek et al. Clinical and Translational Allergy
- Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report
- (2013) A. Wesley Burks et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The US Food and Drug Administration review of the safety and effectiveness of nonstandardized allergen extracts
- (2012) Jay E. Slater et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Standardization of House Dust Mite Extracts in Korea
- (2012) Kyoung Yong Jeong et al. Allergy Asthma & Immunology Research
- European Academy of Allergy and Clinical Immunology task force report on ‘dose-response relationship in allergen-specific immunotherapy’
- (2011) M. A. Calderón et al. ALLERGY
- Maintenance dosing for sublingual immunotherapy by prominent European allergen manufacturers expressed in bioequivalent allergy units
- (2011) Désirée Larenas-Linnemann et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Standardization of allergen products: 1. Detailed characterization of GMP-produced recombinant Bet v 1.0101 as biological reference preparation
- (2009) M. Himly et al. ALLERGY
- The Principle of Homologous Groups in Regulatory Affairs of Allergen Products – A Proposal
- (2008) A.R. Lorenz et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started